News & Trends - Biotechnology
Australia to host VISION biotech leadership programme
For the first time since its inception in 2000, the VISION leadership programme will be held in Australia in February 2020. Targeting current and emerging biotech leaders, VISION provides key leadership insights into the sector trends and skills required to navigate the changing bioindustry landscape.
Leveraging knowledge from across the industry, the course will bring together key executive experts from a range of companies who experience leadership challenges on a day-to-day basis.
These include creating robust intellectual property strategies, portfolio management, nurturing a culture of innovation, managing stringent regulatory requirements and operational limits, dealing with high risk and reward environments and costly timelines while navigating global markets and socio-political landscapes.
Places are limited to 25 delegates to ensure focused discussions, workshops and networking opportunities. Speakers confirmed for 2020 include:
- Barry Buckland, CEO, BiologicB (former VP, Merck)
- Kym Baker, General Manager, Patheon Biologics Australia
- Charles Cooney, Professor, MIT
- Eli Keshavarz-Moore, Professor of Bioprocess Science and Enterprise, UCL
- Trent Munro, Professor, AIBN (former Executive Director, Amgen)
- Chris Nave, Founder and Managing Director, Brandon Capital Partners
- Vicki Salmon, Partner, The IP Asset Partnership
- Rahul Singhvi, COO, Takeda Vaccines
- Neil Weir, CEO, Sitryx Therapeutics Limited (former VP, UCB)
UCL Biochemical Engineering, in collaboration with the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN), will be delivering the VISION Leadership programme in Brisbane from 25 to 28th February 2020.
Visit the VISION webpagefor more information and to register your interest.
Digital & Innovation
Medical drone to reduce health equity gaps in rural and remote Australia
A specialised medical drone which increases accessibility to essential health services such as pathology, medicines, and telehealth services in rural […]
MoreNews & Trends - Pharmaceuticals
We’ve spent more on healthcare, but it’s been worth it
Healthcare expenditure is surging, with Australia now allocating approximately one-tenth of its budget to this sector. This financial uptick prompts […]
MoreNews & Trends - Pharmaceuticals
New partnership to raise the bar in precision oncology in Queensland
Pharma News: The Australian Translational Genomics Centre (ATGC) is teaming up with non-profit research organisation Omico and the PrOSPeCT program […]
MoreNews & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
More